The abstract is read at the publisher; the summary is JClub's.
GATA6- or CDX2-driven reprogramming of mouse embryonic stem cells rapidly converges on cancer-like DNA methylation patterns, including global methylation loss and de novo Polycomb CpG island methylation.
- Why it matters: Extraembryonic tissues and many cancers share unusual methylation landscapes, but the mechanisms that generate these coordinated epigenomic states are unclear.
- What they did: The study reprogrammed mouse embryonic stem cells with GATA6 or CDX2 and tracked genome-wide remodeling, finding synchronized DNA methylation changes with H3K27me3 redistribution and promoter H3K4 methylation loss.
- The result: Cellular senescence models and human aging and cancer cohorts show related, progressively more extensive disruption of the same chromatin boundaries, enabling study of transitions between canonical and non-canonical epigenomic states.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.